1,709 research outputs found

    A Geometric Model for the Coiling of an Elastic Rod Deployed Onto a Moving Substrate

    Get PDF
    We report results from a systematic numerical investigation of the nonlinear patterns that emerge when a slender elastic rod is deployed onto a moving substrate; a system also known as the elastic sewing machine (ESM). The discrete elastic rods (DER) method is employed to quantitatively characterize the coiling patterns, and a comprehensive classification scheme is introduced based on their Fourier spectrum. Our analysis yields physical insight on both the length scales excited by the ESM, as well as the morphology of the patterns. The coiling process is then rationalized using a reduced geometric model (GM) for the evolution of the position and orientation of the contact point between the rod and the belt, as well as the curvature of the rod near contact. This geometric description reproduces almost all of the coiling patterns of the ESM and allows us to establish a unifying bridge between our elastic problem and the analogous patterns obtained when depositing a viscous thread onto a moving surface; a well-known system known as the fluid-mechanical sewing machine (FMSM).National Science Foundation (U.S.) (CMMI-1129894

    Oscillations of confined fibers transported in microchannels

    Full text link
    We investigate the trajectories of rigid fibers as they are transported in a pressure-driven flow, at low Reynolds number, in shallow Hele Shaw cells. The transverse confinement and the resulting viscous friction on these elongated objects, as well as the lateral confinement (i.e. the presence of lateral walls), lead to complex fibers trajectories that we characterize with a combination of microfluidic experiments and simulations using modified Brinkman equations. We show that the transported fiber behaves as an oscillator for which we obtain and analyze a complete state diagram

    Shedding light on pilot-wave phenomena

    Get PDF
    This paper is associated with a video winner of a 2015 APS/DFD Gallery of Fluid Motion Award. The original video is available from the Gallery of Fluid Motion, http://dx.doi.org/10.1103/APS.DFD.2015.GFM.V0064National Science Foundation (U.S.) (Grant CMMI-1333242

    Arc Deformation and Marginal Basin Opening: Japan Sea as a Case Study

    No full text
    Laurent Jolivet est est Professeur à l'Université d'Orléans depuis le 1er Septembre 2009International audienceWe discuss the opening mechanism of the Japan Sea in Miocene time using (1) tectonic and published paleomagnetic data along the eastern margin from the north of Hokkaido Island to Sado Island, (2) a mechanical model which is tested by small-scale physical modeling, and (3) crustal structure and bathymetric features in the Japan Sea which constrain our kinematic model and preopening reconstructions. Our main conclusions are the following. The eastern margin of the Japan Sea was, as a whole, a dextral shear zone about 100 km wide. This conclusion is supported by the existence of a ductile dextral shear zone in Central Hokkaido (Hidaka Mountains) and associated brittle deformation in western Hokkaido and northeastern Honshu. The stress field during the opening (which ended about 12 Ma ago at the end of the middle Miocene) changes from right-lateral transpression in the north to right-lateral transtension in the south. The western margin, along the Korean peninsula, during the same period, also was an active dextral shear zone. Paleomagnetic results indicate that clockwise rotations occurred in the south during the opening and counterclockwise rotations in the north. We propose a model of right-lateral pull-apart deformation with clockwise rotations of rigid blocks in the southern transtensional domain and counterclockwise rotations in the transpressional one. Small-scale physical models show that the clockwise rotation in transtension is possible provided that the eastern boundary (Pacific side) is free of stress. The opening stopped and compression subsequently began about 12 Ma ago. Finally, we show that the dextral shear, which is distributed over the whole Japan Sea area, is accommodated by N-S trending right-lateral faults and rotation of blocks located between these right-lateral faults

    Safety of hyperbaric oxygen therapy in mechanically ventilated patients

    Get PDF
    Background: To evaluate the epidemiology of patients who require mechanical ventilation during hyperbaric oxygen therapy. Materials and methods: One-hundred-fifty patients who required mechanical ventilation during hyperbaric oxygen therapy were prospectively studied during a 6-year period in a French university hyperbaric centre. We analysed the indication of hyperbaric oxygen therapy, agent used for sedation, presence of a chest tube, need for vasopressor agents and tolerance and appearance of side effects. Finally, we compared the outcomes of patients according to the presence or absence of acute respiratory distress syndrome (ARDS). Results: Eleven children and 139 adult patients were included (n = 150) in the study. In both populations, carbon monoxide poisoning (51%) and iatrogenic gas embolism (33%) were the two main causes of intubation and mechanical ventilation. The combination of midazolam and sufentanil was used in 85 (67%) patients. All of the patients were given a bolus of a neuromuscular blocker during the hyperbaric session, despite the presence of ARDS in 35 patients. Patient-ventilator asynchrony was the most frequent side effect in 6 (5%) patients and was often the consequence of suboptimal sedation. Mortality was higher in the group with ARDS (23%). Conclusions: Carbon monoxide poisoning and iatrogenic gas embolism are the two main diseases of the patients who required mechanical ventilation during hyperbaric oxygen therapy in this study. Mechanical ventilation is a safe method for patients during hyperbaric oxygen therapy. Sedation needs to be perfected to avoid patient-ventilator asynchrony.

    The Influence of Voluntary Disclosure, Stock Beta, and Firms Size on Cost of Equity Capital

    Full text link
    This study aimed to examine the effect of voluntary disclosure, stock beta, and firm sizeon the cost of equity capital in manufacturing companies in the period 2013-2015. Thisresearch used purposive sampling method and analyzed by multiple regression, totalsample 39 manufacturing companies listed in BEI period 2013-2015. The results showedthat voluntary disclosure did not affect the cost of equity disclosure, the more voluntarydisclosure had not been able to decrease the occurrence of cost of equity disclosure, betaof stock variables affected the cost of equity capital, because the stock beta was an indicatorto see the condition of the company\u27s financial health, the company had no effect onvoluntary disclosure, this result showed that the size of a company\u27s size could notreduce the risk level

    Arthropod distribution in a tropical rainforest: tackling a four dimensional puzzle

    Get PDF
    Quantifying the spatio-temporal distribution of arthropods in tropical rainforests represents a first step towards scrutinizing the global distribution of biodiversity on Earth. To date most studies have focused on narrow taxonomic groups or lack a design that allows partitioning of the components of diversity. Here, we consider an exceptionally large dataset (113,952 individuals representing 5,858 species), obtained from the San Lorenzo forest in Panama, where the phylogenetic breadth of arthropod taxa was surveyed using 14 protocols targeting the soil, litter, understory, lower and upper canopy habitats, replicated across seasons in 2003 and 2004. This dataset is used to explore the relative influence of horizontal, vertical and seasonal drivers of arthropod distribution in this forest. We considered arthropod abundance, observed and estimated species richness, additive decomposition of species richness, multiplicative partitioning of species diversity, variation in species composition, species turnover and guild structure as components of diversity. At the scale of our study (2km of distance, 40m in height and 400 days), the effects related to the vertical and seasonal dimensions were most important. Most adult arthropods were collected from the soil/litter or the upper canopy and species richness was highest in the canopy. We compared the distribution of arthropods and trees within our study system. Effects related to the seasonal dimension were stronger for arthropods than for trees. We conclude that: (1) models of beta diversity developed for tropical trees are unlikely to be applicable to tropical arthropods; (2) it is imperative that estimates of global biodiversity derived from mass collecting of arthropods in tropical rainforests embrace the strong vertical and seasonal partitioning observed here; and (3) given the high species turnover observed between seasons, global climate change may have severe consequences for rainforest arthropods1012CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQSolVin-Solvay SA; Smithsonian Institution; Smithsonian Tropical Research Institute; United Nations Environment Programme; Smithsonian Institution; Smithsonian National Museum of Natural History; European Science Foundation (ESF); Global Canopy Programme; Czech Science foundation GACR grant; European Social Fund (ESF); Ministry of Education, Youth & Sports - Czech Republic; French National Research Agency (ANR); Research Council of Norway; Grant Agency of the Czech Republi

    BMJ Med

    Get PDF
    OBJECTIVE: To evaluate the efficacy of covid-19 convalescent plasma to treat patients admitted to hospital for moderate covid-19 disease with or without underlying immunodeficiency (CORIPLASM trial). DESIGN: Open label, randomised clinical trial. SETTING: CORIMUNO-19 cohort (publicly supported platform of open label, randomised controlled trials of immune modulatory drugs in patients admitted to hospital with moderate or severe covid-19 disease) based on 19 university and general hospitals across France, from 16 April 2020 to 21 April 2021. PARTICIPANTS: 120 adults (n=60 in the covid-19 convalescent plasma group, n=60 in the usual care group) admitted to hospital with a positive SARS-CoV2 test result, duration of symptoms 40. MAIN OUTCOME MEASURES: Primary outcomes were proportion of patients with a WHO Clinical Progression Scale score of ≄6 on the 10 point scale on day 4 (higher values indicate a worse outcome), and survival without assisted ventilation or additional immunomodulatory treatment by day 14. Secondary outcomes were changes in WHO Clinical Progression Scale scores, overall survival, time to discharge, and time to end of dependence on oxygen supply. Predefined subgroups analyses included immunosuppression status, duration of symptoms before randomisation, and use of steroids. RESULTS: 120 patients were recruited and assigned to covid-19 convalescent plasma (n=60) or usual care (n=60), including 22 (covid-19 convalescent plasma) and 27 (usual care) patients who were immunocompromised. 13 (22%) patients who received convalescent plasma had a WHO Clinical Progression Scale score of ≄6 at day 4 versus eight (13%) patients who received usual care (adjusted odds ratio 1.88, 95% credible interval 0.71 to 5.24). By day 14, 19 (31.6%) patients in the convalescent plasma group and 20 (33.3%) patients in the usual care group needed ventilation, additional immunomodulatory treatment, or had died. For cumulative incidence of death, three (5%) patients in the convalescent plasma group and eight (13%) in the usual care group died by day 14 (adjusted hazard ratio 0.40, 95% confidence interval 0.10 to 1.53), and seven (12%) patients in the convalescent plasma group and 12 (20%) in the usual care group by day 28 (adjusted hazard ratio 0.51, 0.20 to 1.32). In a subgroup analysis performed in patients who were immunocompromised, transfusion of covid-19 convalescent plasma was associated with mortality (hazard ratio 0.39, 95% confidence interval 0.14 to 1.10). CONCLUSIONS: In this study, covid-19 convalescent plasma did not improve early outcomes in patients with moderate covid-19 disease. The efficacy of convalescent plasma in patients who are immunocompromised should be investigated further. TRIAL REGISTRATION: ClinicalTrials.gov NCT04345991
    • 

    corecore